"In this report, we compare the implications of our framework to the prior CDC guidance for prioritization of pandemic influenza vaccine allocation and suggest candidate groups who should be given serious consideration for inclusion in the top allocation tier when vaccine availability is limited and in a second tier (those also prioritized before the general public) if/when more vaccine supply becomes available. We also discuss how COVID-19 vaccines should be distributed so as to reach these 2 tiers." - Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States
Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.